11 November 2015
Biotech company Curetis listed
Curetius, a German biotech company, becomes listed on the Amsterdam exchange. Curetis develops and sells tests for the diagnosis of infectious diseases and will use the proceeds from the IPO to develop new tests.
Update: after a merger with American peer OpGen Curetis is de-listed again on 4 May 2020.